Related Experiment Video
Updated: May 21, 2026
10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
The 18th European symposium on quantitative structure-activity relationships
Anna Tsantili-Kakoulidou1, Dimitris K Agrafiotis
1University of Athens, School of Pharmacy, Department of Pharmaceutical Chemistry, Panepistimiopolis, Zografou, Athens 157 71, Greece Tsantili@pharm.uoa.gr.
Expert Opinion on Drug Discovery
|June 1, 2012
Summary
The 18th European Symposium on Quantitative Structure-Activity Relationships (QSAR) focused on discovery informatics and drug design. Advances in QSAR and informatics tools were discussed for developing safer and more effective drugs.
Area of Science:
- Medicinal Chemistry
- Cheminformatics
- Bioinformatics
- Pharmacoinformatics
- Drug Discovery
Background:
- The 18th European Symposium on Quantitative Structure-Activity Relationships (QSAR) convened in Rhodes, Greece.
- The symposium was organized by the Hellenic Society of Medicinal Chemistry and the Cheminformatics and QSAR Society.
- Co-sponsorship was provided by the European Federation of Medicinal Chemistry.
Purpose of the Study:
- To discuss the impact of informatics (chemoinformatics, bioinformatics, pharmacoinformatics) on drug discovery.
- To explore the broader context of biological complexity in drug development.
- To highlight recent scientific and technological advances in QSAR.
Main Methods:
- The symposium featured discussions and presentations on QSAR and informatics.
- Key presentations focused on the application of these tools in drug discovery.
- The event served as a platform for sharing the latest advancements.
Main Results:
- Latest scientific and technological advances in QSAR were presented.
- The impact of informatics on drug discovery was thoroughly addressed.
- Discussions highlighted QSAR's role in discovering new drugs.
Conclusions:
- QSAR and informatics are crucial tools for modern drug discovery.
- The symposium underscored the importance of interdisciplinary approaches in addressing biological complexity.
- Future drug development will likely leverage advanced informatics and QSAR methodologies.
More Related Videos
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:30Quantitative Aspects of Drug-Receptor Interaction
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
02:37VSEPR Theory
Valence shell electron-pair repulsion theory (VSEPR theory) enables us to predict the molecular structure around a central atom from an examination of the number of bonds and lone electron pairs in its Lewis structure. The VSEPR model assumes that electron pairs in the valence shell of a central atom will adopt an arrangement that minimizes repulsions between these electron pairs by maximizing the distance between them. The electrons in the valence shell of a central atom form either bonding...
02:52VSEPR Theory and the Basic Shapes
Overview of VSEPR Theory
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
01:22Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...